You have 9 free searches left this month | for more free features.

Multi-Omics Approaches

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma, IDH-wildtype Trial in Rome (Biological biomarker analysis)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • Biological biomarker analysis
  • Rome, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Jul 3, 2023

Gynecological Rare Pathological Tumors

Not yet recruiting
  • Rare Gynecological Tumors
  • Multi-omics Analysis
    • (no location specified)
    Aug 3, 2023

    Lung Cancer Multi-omics Digital Human Avatars for Integrating

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • surgical resection
    • (no location specified)
    Apr 4, 2023

    Gastric Cancer, Multi-omics, Diagnosis Trial in Hangzhou (Without any intervention)

    Active, not recruiting
    • Gastric Cancer
    • +2 more
    • Without any intervention
    • Hangzhou, Zhejiang, China
      Cancer Hospital of the University of Chinese Academy of Sciences
    Nov 15, 2023

    Primary Hypertension Trial (Amlodipine, Olmesartan, Hydrochlorothiazide)

    Not yet recruiting
    • Primary Hypertension
    • (no location specified)
    Jun 15, 2023

    Diabetes, Type 2, PreDiabetes Trial in Stanford (Dietary intervention)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • PreDiabetes
    • Dietary intervention
    • Stanford, California
      Stanford University
    Aug 23, 2023

    Genetic Predisposition Trial in Tübingen (Multi-OMICS)

    Recruiting
    • Genetic Predisposition
    • Multi-OMICS
    • Tübingen, Germany
      University Hospital Tübingen
    May 17, 2022

    Acute Myeloid Leukemia Trial in Taipei

    Enrolling by invitation
    • Acute Myeloid Leukemia
      • Taipei, Taiwan
        National Taiwan University Hospital
      Aug 9, 2023

      Lung Tumor Malignant Trial in Milano (SBRT, Surgery)

      Not yet recruiting
      • Lung Neoplasm Malignant
      • SBRT
      • Surgery
      • Milano, MI, Italy
        Istituto Europeo di Oncologia IRCCS
      Jul 26, 2023

      Primary Sclerosing Cholangitis, IBD Trial in Stanford (Rosuvastatin)

      Recruiting
      • Primary Sclerosing Cholangitis
      • Inflammatory Bowel Diseases
      • Stanford, California
        Stanford University
      Jun 12, 2023

      Nervous System Diseases, Cardiovascular and Cerebrovascular Diseases Trial in Jinan

      Recruiting
      • Nervous System Diseases
      • Cardiovascular and Cerebrovascular Diseases
        • Jinan, China
          The First Affiliated Hospital of Shandong First Medical Universi
        Oct 19, 2023

        Phlegm-heat Syndrome in Ischemic Stroke Based on Multi-omics

        Not yet recruiting
        • Ischemic Stroke, Acute
          • (no location specified)
          Nov 19, 2022

          Lifestyle and Multi-omics Analysis in Autoimmune Gastritis

          Recruiting
          • Autoimmune Gastritis
          • Microbiome, metabolome, transcriptome, genome
          • Shanghai, Shanghai, China
            Shanghai Institute of Digestive Disease
          Apr 17, 2023

          Minimal Residual Disease Using Multi-omics Approach

          Not yet recruiting
          • Pancreatic Ductal Adenocarcinoma
          • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
          • Shanghai, China
            Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
          Nov 29, 2023

          Tongue Coating in Malignant Tumors of Digestive Tract

          Recruiting
          • Malignant Tumors of Digestive Tract
          • Tongue coating sample collection and multi-omics analysis
          • Hangzhou, Zhejiang, China
            Cancer Hospital of the University of Chinese Academy of Sciences
          Mar 31, 2023

          Multi-omics Analysis of Chronic Kidney Disease

          Recruiting
          • Potential Mechanisms Underlying the Microbiota-Gut-Kidney Axis in CKD
          • renal function
          • Shanghai, Shanghai, China
            Department of Nephrolgoy, Shanghai 10th People's Hospital
          Sep 13, 2022

          Drug Intervention Study of Spondyloarthritis

          Enrolling by invitation
          • Spondylarthritis
          • questionnaire survey
          • Wenzhou, Zhejiang, China
            Xiaobing Wang
          Aug 11, 2022

          Crohn Disease, Ulcerative Colitis Trial in Guangzhou (Biologics)

          Recruiting
          • Crohn Disease
          • Ulcerative Colitis
          • Guangzhou, Guangdong, China
            The Sixth Affiliated Hospital, Sun Yat-sen University
          Sep 14, 2022

          Host-microbiome Interaction in Chronic Obstructive Pulmonary

          Not yet recruiting
          • COPD Exacerbation
          • Bronchiectasis With Acute Exacerbation
          • No intervention
          • Shanghai, Shanghai, China
            Ruijin Hospital, Medical School of Shanghai Jiaotong University
          Feb 20, 2023

          Systemic Lupus Erythematosus Trial in Nanjing

          Not yet recruiting
          • Systemic Lupus Erythematosus
            • Nanjing, China
              Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing
            Sep 9, 2022

            NAFLD, Obesity, Morbid, Comorbidities and Coexisting Conditions Trial in Reus (To propose diagnostic tests for liver diseases

            Recruiting
            • NAFLD
            • +2 more
            • To propose diagnostic tests for liver diseases before surgical decisions.
            • Reus, Tarragona, Spain
              Hospital Universitari Sant Joan
            Sep 23, 2022

            Ebola Disease, Marburg Disease Trial in Atlanta (Ad26 Zaire Ebola Vaccine, MVA Multi-Filo Ebola Vaccine)

            Completed
            • Ebola Disease
            • Marburg Disease
            • Ad26 Zaire Ebola Vaccine
            • MVA Multi-Filo Ebola Vaccine
            • Atlanta, Georgia
              Emory Children's Center - Pediatric Infectious Diseases
            Feb 18, 2021

            Immunotherapy, Gastric Cancer, Rectal Cancer Trial (Terelizumab, CapeOx, Trastuzumab)

            Not yet recruiting
            • Immunotherapy
            • +4 more
            • (no location specified)
            Aug 24, 2022

            Colorectal Cancer Based on Plasma Multi-omics Combining With

            Recruiting
            • Colorectal Adenoma
            • Colorectal Cancer
            • Colonoscopy
            • +2 more
            • Beijing, Beijing, China
            • +4 more
            Oct 20, 2022